BCTX

BriaCell Therapeutics Corp.

0.80 USD
-0.00 (-0.11%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

BriaCell Therapeutics Corp. stock is down -33.42% since 30 days ago. The next earnings date is Oct 23, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 13 July’s closed higher than June.

About BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. engages in developing immunotherapies for the treatment of cancer. Lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors. Company also has a cooperative research and development agreement with the National Cancer Institute.